In November 2023, Selecta Biosciences Inc. (NASDAQ: SELB) merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease. The combined company will focus on advancing Cartesian’s wholly owned pipeline, including Descartes-08, Cartesian’s clinical-stage lead product candidate being evaluated in patients with myasthenia gravis and other autoimmune diseases. For more information about the company and updates, please visit https://www.cartesiantherapeutics.com/ or follow us on LinkedIn @Cartesian-Therapeutics.
View Top Employees from Cartesian TherapeuticsWebsite | http://www.cartesiantherapeutics.com |
Employees | 45 (24 on RocketReach) |
Founded | 2016 |
Technologies |
JavaScript,
HTML,
PHP
+17 more
(view full list)
|
Industry | Biotechnology Research, Immunotherapy, Oncology, Molecular Biology, Immunology |
Looking for a particular Cartesian Therapeutics employee's phone or email?
Metin Kurtoglu is the COO of Cartesian Therapeutics.
24 people are employed at Cartesian Therapeutics.
Cartesian Therapeutics is based in Gaithersburg, Maryland.